Study to establish the safety of using antipyretics with febrile seizures and assess whether acetaminophen could reduce the recurrent risk of febrile seizure in the same fever episode. - AAA study

Department of Pediatrics, Hirakata City Hospital 2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan Tel: +81-72-847-2821; Fax: +81-72-847-28250 sites500 target enrollmentJanuary 1, 2018

Conditionsfebrile seizure

Overview

Phase: 未知
Intervention: Not specified
Conditions: febrile seizure
Sponsor: Department of Pediatrics, Hirakata City Hospital 2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan Tel: +81-72-847-2821; Fax: +81-72-847-2825
Enrollment: 500
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

January 1, 2018

End Date

April 30, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Department of Pediatrics, Hirakata City Hospital 2-14-1 Kinya-honmachi, Hirakata, Osaka 573-1013, Japan Tel: +81-72-847-2821; Fax: +81-72-847-2825

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\)Patients with seizure over 15 minutes were excluded from the study as status epilepticus. 2\)Patients with diarrhea were excluded because it is difficult to put suppositories and other pathologies may be involved such as convulsion with mild gastroenteritis . 3\)Patients with epilepsy, chromosomal abnormality, inherited metabolic diseases, brain tumor, cerebral hemorrhage, hydrocephalus, and those with a history of intracranial surgery were excluded. 4\)Patients who were used to prevent febrile seizuress with diazepam suppository were excluded. 5\)Patients take antihistamine that may increase seizure susceptibility in patients with febrile seizures were also excluded.